CIK 0001551152 · Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320375147
- Phone
- (847) 932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | Quaggin Susan E Director | Grant or award · Stock Equivalent Units | +84 | $177.70 | $15K | 401 |
| 2024-12-16 | Buckbee Kevin K SVP, CONTROLLER | Option exercise | +1,800 | $93.50 | $168K | 8,783 |
| 2024-12-16 | Buckbee Kevin K SVP, CONTROLLER | Sale | −1,800 | $172.24 | $310K | 6,983 |
| 2024-12-16 | Buckbee Kevin K SVP, CONTROLLER | Option exercise · Option (Right to buy) | −1,800 | $93.50 | $168K | 12,111 |
| 2024-09-30 | RAPP EDWARD J Director | Grant or award · Stock Equivalent Units | +164 | $197.48 | $32K | 26,544 |
| 2024-09-30 | Alpern Robert J Director | Grant or award · Stock Equivalent Units | +37 | $197.48 | $7K | 9,655 |
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +5,900 | 36,125 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +1,572 | 37,697 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +1,476 | 39,173 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +2,140 | 41,313 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award · Option (Right to buy) | +13,868 | 13,868 |
Page 12 of 12 · 231 trades